Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Deutsche Bank AG

Key Points

• Deutsche Bank AG has reduced its stake in Sabra Healthcare REIT, Inc. by 42.7% during the first quarter, now owning 1,195,901 shares valued at approximately $20.89 million.
• Despite Deutsche Bank's decrease, several hedge funds increased their positions in Sabra Healthcare, with New Age Alpha Advisors expanding their stake by 371.2%.
• The company recently announced a quarterly dividend of $0.30 per share, representing a yield of 6.5%, with a payout ratio of 157.89%.

Deutsche Bank AG cut its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 42.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,195,901 shares of the real estate investment trust's stock after selling 890,891 shares during the quarter. Deutsche Bank AG owned approximately 0.50% of Sabra Healthcare REIT worth $20,892,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of SBRA. Allspring Global Investments Holdings LLC purchased a new position in Sabra Healthcare REIT in the first quarter valued at $298,000. New York State Teachers Retirement System grew its stake in Sabra Healthcare REIT by 12.1% during the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock valued at $5,619,000 after acquiring an additional 34,591 shares in the last quarter. M&T Bank Corp grew its stake in Sabra Healthcare REIT by 2.1% during the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock valued at $905,000 after acquiring an additional 1,059 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in Sabra Healthcare REIT by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock valued at $331,000 after purchasing an additional 853 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC acquired a new position in Sabra Healthcare REIT in the 1st quarter valued at about $180,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Up 1.1%

Sabra Healthcare REIT stock traded up $0.21 during mid-day trading on Monday, reaching $18.67. 631,594 shares of the company's stock were exchanged, compared to its average volume of 2,449,939. The company has a market cap of $4.48 billion, a P/E ratio of 24.57, a P/E/G ratio of 1.53 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a fifty day moving average of $18.33 and a 200-day moving average of $17.62.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period in the prior year, the firm posted $0.36 EPS. The company's quarterly revenue was up 7.4% compared to the same quarter last year. Sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is 157.89%.

Analyst Ratings Changes

Several brokerages have recently commented on SBRA. JMP Securities upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. Scotiabank upped their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.00.

Insider Activity at Sabra Healthcare REIT

In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares of the company's stock, valued at $1,179,289.50. This trade represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.10% of the stock is owned by company insiders.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.